Verb Technology Company, Inc.

According to the Complaint, the Company made false and misleading statements to the market. Verb did not have a contract with Oracle to jointly bring to market the Company’s notifiCRM product. Based on this fact, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Verb, investors suffered damages.

-->

CannTrust Holdings Inc.

According to the Complaint, the Company made false and misleading statements to the market. CannTrust was growing cannabis in its Pelham greenhouse without regulatory approval as the applications were still pending. In general, the Pelham greenhouse did not comply with regulations. This resulted in an increased likelihood of the Company facing an inventory hold by Health Canada, resulting in the Company’s customers seeking products from other cannabis suppliers. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about CannTrust, investors suffered damages.

-->

Diebold Nixdorf, Inc.

According to the Complaint, the Company made false and misleading statements to the market. Diebold experienced delays and slowdowns in a number of areas, including system rollouts, customer decision-making, and the order-to-revenue conversion cycle. These delays had a negative impact on the Company’s operations and its service business. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Diebold, investors suffered damages.

-->

Fred’s Inc.

According to the Complaint, the Company made false and misleading statements to the market. Fred’s entered into an agreement with Walgreens and Rite Aid Corp. to purchase 865 Rite Aid stores as a part of a merger plan between Walgreens and Rite Aid. The Company downplayed regulatory risks and disputed reports in the media that the merger was facing trouble. Fred’s also represented that it had inside information from the FTC that the Walgreens deal would close. Walgreens and Rite Aid announced on June 29, 2017, that they had terminated their merger plans, including the store sale to Fred’s. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Fred’s, investors suffered damages.

-->

FedEx Corporation

According to the Complaint, the Company made false and misleading statements to the market. FedEx acquisition TNT Express N.V.’s (“TNT”) package volume growth slowed as customers took their business to competitors following the Company’s 2017 cyberattack. TNT’s product mix shifted to low-margin freight from high-margin parcel service. The restoration of TNT’s network took longer and cost more than the Company had disclosed. FedEx was not on track to achieve the targets it set for synergy with TNT. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about FedEx, investors suffered damages.

-->

EQT Corporation

According to the Complaint, the Company made false and misleading statements to the market. EQT announced on June 19, 2017, that it entered into an agreement to acquire Rice, a rival gas producer. The Company claimed the acquisition would allow it to achieve “a 50% increase in average lateral [drilling] lengths,” touting that the merger would produce $2.5 billion in synergies, and $100 million in savings for 2018. In fact, these synergies and cost savings were not realized. EQT reported poor third-quarter results on October 25, 2018, including increased total costs, disclosing that its estimated capital expenditures for well development would increase by $300 million in 2018. At the same time, the Company reduced its full-year forecast for 2018. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about EQT, investors suffered damages.

-->

Teva Pharmaceutical Industries Ltd.

According to the Complaint, the Company made false and misleading statements to the market. Teva participated in a massive price-fixing scheme across the entire industry from at least 2012, despite the Company’s denials. Although Teva was not the only participant in the scheme, it was the principal organization behind the anticompetitive action. Teva employees were so deeply involved in the price-fixing scheme that they were personally named as defendants by the Attorneys General of almost every state in the nation. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Teva, investors suffered damages.

-->

Anheuser-Busch InBev SA/NV

According to the Complaint, the Company made false and misleading statements to the market. Anheuser-Busch’s cost-cutting measures had been implemented to the greatest extent possible. At the same time, key emerging markets suffered from currency devaluation and cost inflation, negatively impacting the Company’s margins. In a variety of key markets, the Company suffered from lower growth than expected. In fact, Anheuser-Busch would not be able to maintain its current dividend while still meeting deleveraging targets, and it was at risk of a credit downgrade. The Company filed false and misleading disclosures to the SEC including on liquidity and working capital, and risk factors the Company was experiencing. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Anheuser-Busch, investors suffered damages.

-->

Aclaris Therapeutics, Inc.

According to the Complaint, the Company made false and misleading statements to the market. Aclaris’ advertising touted the safety of ESKATA as well as overstating its efficacy to drive sales. This advertising was likely to bring the Company under regulatory scrutiny. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Aclaris, investors suffered damages.

-->

Zuora, Inc.

According to the Complaint, the Company made false and misleading statements to the market. Zuora focused on implementing its RevPro product for new customers ahead of the compliance deadline for accounting standard ASC 606. The Company failed to maintain adequate resources to facilitate the integration of RevPro with its core business. The year-long focus on RevPro after its acquisition and the delay in integration materially impacted the Company’s results. Because of the limited market for RevPro after the ASC 606 deadline, demand for the solution could be reasonably expected to decline. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Zuora, investors suffered damages.

-->